Phase I clinical trial of a peptide vaccine combined with tegafur-uracil plus leucovorin for treatment of advanced or recurrent colorectal cancer

By            

Oncology Reports, Vol. 29, Iss. 3, 2013-01 ,pp. : 951-959

Spandidos Publications

Access to resources Recommend Favorite

Biochemical modulation of 5-fluorouracil by leucovorin with or without interferon- -2c in patients with advanced colorectal cancer: final results of a randomised phase III study

By Hausmaninger H.   Moser R.   Samonigg H.   Mlineritsch B.   Schmidt H.   Pecherstorfer M.   Fridrik M.   Kopf C.   Nitsche D.   Kaider A.   Ludwig H.  

European Journal of Cancer, Vol. 35, Iss. 3, 1999-03 ,pp. : 380-385

Elsevier

Access to resources Recommend Favorite

Phase II Study of Gemcitabine, UFT and Leucovorin in Patients with Advanced Pancreatic Cancer

By Kim Tae Won   Kang Hae Jin   Ahn Jin Hee   Lee Keehyun   Chang Heung Moon   Kang Yoon Koo   Lee Jung Shin  

Acta Oncologica, Vol. 41, Iss. 7-8, 2002-11 ,pp. : 689-694

Informa Healthcare

Access to resources Recommend Favorite

Treatment of advanced gastric cancer with oral etoposide, leucovorin and tegafur: experience with an oral modification of the etoposide, leucovorin and 5-fluorouracil (ELF) regimen

By Raderer M.   Kornek G.V.   Hejna M.H.L.   Miholic J.   Weinlaender G.   Brodowicz T.   Fiebiger W.C.C.   Valencak J.B.   Scheithauer W.  

European Journal of Cancer, Vol. 34, Iss. 7, 1998-06 ,pp. : 1128-1130

Elsevier

Access to resources Recommend Favorite

Oral Tegafur and Folinic Acid for the Treatment of Advanced Colorectal Cancer

By Isla M.D.   Mayordomo J.I.   Cajal R.   Saenz A.   Escudero P.   Tres A.  

European Journal of Cancer, Vol. 33, Iss. 1, 1997-01 ,pp. : 166-167

Elsevier

Access to resources Recommend Favorite